Suzhou BioTOP Technical Service Co (BioTOP) bought the newest edition of Chinese Pharmacopoeia on August 14 and plans to adopt the pharmacopoeia as its testing principles since the end of September 2015.

The effort aims to improve the accuracy of tests and offer reliable testing service.

Published by Chinese Pharmacopoeia Commission, the 2015 edition of Chinese Pharmacopoeia helps enhance the supervision of drug safety and validity. It reflects the current development of China's medical industry and medical testing technologies, with the hope of improving the quality of domestic medicine and boosting the industry's development.

BioTOP, based in Suzhou, Jiangsu province, is an independent third-party agency which provides analytical and testing services accredited with the China National Accreditation Service for Conformity Assessment (CNAS). Its management strictly complies with Good Manufacturing Practice (GMP) standards.